Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an announcement.
Chimeric Therapeutics Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for July 23, 2025, to be held both physically in Victoria and virtually online. This meeting provides an opportunity for shareholders to participate and vote on company matters, reflecting the company’s commitment to engaging with its stakeholders and ensuring their involvement in decision-making processes.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative cell therapies for cancer treatment.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.06M
For a thorough assessment of CHM stock, go to TipRanks’ Stock Analysis page.